Laparoscopic Uterine Vessel Occlusion in the Treatment of Women with Symptomatic Uterine Myomas with and without Adding Laparoscopic Myomectomy: 4-Year Results

Peng Hui Wang, Wei Min Liu, Jong Ling Fuh, Hsiang Tai Chao, Kuan Chong Chao, Chiou Chong Yuan

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Study Objective: To estimate the necessity of laparoscopic myomectomy (LM) in the treatment of women with symptomatic uterine myomas who are undergoing laparoscopic uterine vessel occlusion (LUVO). Design: A comparative observational study (Canadian Task Force classification II-3). Setting: Medical center. Patients: In all, 163 patients with symptomatic, uncomplicated myomas warranting myomectomy. A total of 95 patients underwent LUVO and 68 underwent LUVO with LM. Interventions: Symptomatic myomas treated by LUVO with or without LM. Measurements and Main Results: The outcome was measured by comparing surgical parameters, immediate postoperative parameters, 4-year evaluations of symptom control, and reintervention (hysterectomy or myomectomy) in both groups. The general characteristics of the patients were similar in both groups. No statistical differences existed in complications, success rate, or immediate satisfaction rate between the 2 groups. Compared with LUVO+LM, LUVO had advantages in surgical and immediate postoperative parameters, including less operative time, minimal blood loss, and rapid postoperative recovery; however, LUVO+LM was superior to LUVO in terms of a better and longer duration of symptom relief, a higher level of satisfaction, and avoidance of reintervention. Of the sexually active patients who did not use contraception, 58.8% (10/17) and 66.7% (4/6) became pregnant in groups I and II, respectively (no statistical significance). Conclusion: Although LUVO is a less invasive procedure in the treatment of most women with symptomatic myomas, it is also less effective for symptom control and has shorter durable symptom relief compared with LUVO+LM. Reoperation can be avoided in most patients who are treated with LUVO+LM.

Original languageEnglish
Pages (from-to)712-718
Number of pages7
JournalJournal of Minimally Invasive Gynecology
Volume15
Issue number6
DOIs
Publication statusPublished - Nov 2008

Fingerprint

Uterine Myomectomy
Myoma
Therapeutics
Postoperative Hemorrhage
Symptom Assessment
Advisory Committees
Operative Time
Hysterectomy
Contraception
Reoperation
Observational Studies

Keywords

  • Laparoscopic myomectomy
  • Laparoscopic uterine vessel occlusion
  • Myoma

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Laparoscopic Uterine Vessel Occlusion in the Treatment of Women with Symptomatic Uterine Myomas with and without Adding Laparoscopic Myomectomy : 4-Year Results. / Wang, Peng Hui; Liu, Wei Min; Fuh, Jong Ling; Chao, Hsiang Tai; Chao, Kuan Chong; Yuan, Chiou Chong.

In: Journal of Minimally Invasive Gynecology, Vol. 15, No. 6, 11.2008, p. 712-718.

Research output: Contribution to journalArticle

@article{0f0c9dad0df94ee98f7683a8a3122f07,
title = "Laparoscopic Uterine Vessel Occlusion in the Treatment of Women with Symptomatic Uterine Myomas with and without Adding Laparoscopic Myomectomy: 4-Year Results",
abstract = "Study Objective: To estimate the necessity of laparoscopic myomectomy (LM) in the treatment of women with symptomatic uterine myomas who are undergoing laparoscopic uterine vessel occlusion (LUVO). Design: A comparative observational study (Canadian Task Force classification II-3). Setting: Medical center. Patients: In all, 163 patients with symptomatic, uncomplicated myomas warranting myomectomy. A total of 95 patients underwent LUVO and 68 underwent LUVO with LM. Interventions: Symptomatic myomas treated by LUVO with or without LM. Measurements and Main Results: The outcome was measured by comparing surgical parameters, immediate postoperative parameters, 4-year evaluations of symptom control, and reintervention (hysterectomy or myomectomy) in both groups. The general characteristics of the patients were similar in both groups. No statistical differences existed in complications, success rate, or immediate satisfaction rate between the 2 groups. Compared with LUVO+LM, LUVO had advantages in surgical and immediate postoperative parameters, including less operative time, minimal blood loss, and rapid postoperative recovery; however, LUVO+LM was superior to LUVO in terms of a better and longer duration of symptom relief, a higher level of satisfaction, and avoidance of reintervention. Of the sexually active patients who did not use contraception, 58.8{\%} (10/17) and 66.7{\%} (4/6) became pregnant in groups I and II, respectively (no statistical significance). Conclusion: Although LUVO is a less invasive procedure in the treatment of most women with symptomatic myomas, it is also less effective for symptom control and has shorter durable symptom relief compared with LUVO+LM. Reoperation can be avoided in most patients who are treated with LUVO+LM.",
keywords = "Laparoscopic myomectomy, Laparoscopic uterine vessel occlusion, Myoma",
author = "Wang, {Peng Hui} and Liu, {Wei Min} and Fuh, {Jong Ling} and Chao, {Hsiang Tai} and Chao, {Kuan Chong} and Yuan, {Chiou Chong}",
year = "2008",
month = "11",
doi = "10.1016/j.jmig.2008.08.005",
language = "English",
volume = "15",
pages = "712--718",
journal = "Journal of Minimally Invasive Gynecology",
issn = "1553-4650",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - Laparoscopic Uterine Vessel Occlusion in the Treatment of Women with Symptomatic Uterine Myomas with and without Adding Laparoscopic Myomectomy

T2 - 4-Year Results

AU - Wang, Peng Hui

AU - Liu, Wei Min

AU - Fuh, Jong Ling

AU - Chao, Hsiang Tai

AU - Chao, Kuan Chong

AU - Yuan, Chiou Chong

PY - 2008/11

Y1 - 2008/11

N2 - Study Objective: To estimate the necessity of laparoscopic myomectomy (LM) in the treatment of women with symptomatic uterine myomas who are undergoing laparoscopic uterine vessel occlusion (LUVO). Design: A comparative observational study (Canadian Task Force classification II-3). Setting: Medical center. Patients: In all, 163 patients with symptomatic, uncomplicated myomas warranting myomectomy. A total of 95 patients underwent LUVO and 68 underwent LUVO with LM. Interventions: Symptomatic myomas treated by LUVO with or without LM. Measurements and Main Results: The outcome was measured by comparing surgical parameters, immediate postoperative parameters, 4-year evaluations of symptom control, and reintervention (hysterectomy or myomectomy) in both groups. The general characteristics of the patients were similar in both groups. No statistical differences existed in complications, success rate, or immediate satisfaction rate between the 2 groups. Compared with LUVO+LM, LUVO had advantages in surgical and immediate postoperative parameters, including less operative time, minimal blood loss, and rapid postoperative recovery; however, LUVO+LM was superior to LUVO in terms of a better and longer duration of symptom relief, a higher level of satisfaction, and avoidance of reintervention. Of the sexually active patients who did not use contraception, 58.8% (10/17) and 66.7% (4/6) became pregnant in groups I and II, respectively (no statistical significance). Conclusion: Although LUVO is a less invasive procedure in the treatment of most women with symptomatic myomas, it is also less effective for symptom control and has shorter durable symptom relief compared with LUVO+LM. Reoperation can be avoided in most patients who are treated with LUVO+LM.

AB - Study Objective: To estimate the necessity of laparoscopic myomectomy (LM) in the treatment of women with symptomatic uterine myomas who are undergoing laparoscopic uterine vessel occlusion (LUVO). Design: A comparative observational study (Canadian Task Force classification II-3). Setting: Medical center. Patients: In all, 163 patients with symptomatic, uncomplicated myomas warranting myomectomy. A total of 95 patients underwent LUVO and 68 underwent LUVO with LM. Interventions: Symptomatic myomas treated by LUVO with or without LM. Measurements and Main Results: The outcome was measured by comparing surgical parameters, immediate postoperative parameters, 4-year evaluations of symptom control, and reintervention (hysterectomy or myomectomy) in both groups. The general characteristics of the patients were similar in both groups. No statistical differences existed in complications, success rate, or immediate satisfaction rate between the 2 groups. Compared with LUVO+LM, LUVO had advantages in surgical and immediate postoperative parameters, including less operative time, minimal blood loss, and rapid postoperative recovery; however, LUVO+LM was superior to LUVO in terms of a better and longer duration of symptom relief, a higher level of satisfaction, and avoidance of reintervention. Of the sexually active patients who did not use contraception, 58.8% (10/17) and 66.7% (4/6) became pregnant in groups I and II, respectively (no statistical significance). Conclusion: Although LUVO is a less invasive procedure in the treatment of most women with symptomatic myomas, it is also less effective for symptom control and has shorter durable symptom relief compared with LUVO+LM. Reoperation can be avoided in most patients who are treated with LUVO+LM.

KW - Laparoscopic myomectomy

KW - Laparoscopic uterine vessel occlusion

KW - Myoma

UR - http://www.scopus.com/inward/record.url?scp=54349114245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54349114245&partnerID=8YFLogxK

U2 - 10.1016/j.jmig.2008.08.005

DO - 10.1016/j.jmig.2008.08.005

M3 - Article

C2 - 18971134

AN - SCOPUS:54349114245

VL - 15

SP - 712

EP - 718

JO - Journal of Minimally Invasive Gynecology

JF - Journal of Minimally Invasive Gynecology

SN - 1553-4650

IS - 6

ER -